SHANGHAI, Nov 12 (Reuters) – China has approved Eli Lilly's weight loss pill orforglipron, the country's medicine regulator said on Thursday. (Reporting by Andrew Silver; additional reporting from
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Spurs withstand Bulls' early surge, win 10th straight game
VIDEO SHOWS: HIGHLIGHTS OF SAN ANTONIO SPURS V CHICAGO BULLS IN REGULAR SEASON NBA GAME…
UPDATE 2-Taiwan's Foxconn bullish on outlook but warns about supply chain tightness
* Q3 net profit T$77.5 bln, well ahead of forecast * Company sees strong AI…
Nvidia board meets to decide CEO Huang's future as leadership crisis deepens
By Aishwarya Venugopal and Alexandra Alper Nov 11 (Reuters) - Nvidia's board is meeting late…
